Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations are in order for postdoctoral research scientist Dr Christoph Treiber who has been awarded a Starting Grant from the European Research Council. His funded project will investigate the genetic components that may contribute to diversity of brain function and behaviour.

15 fruit fly brains in a colourful grid design © Gil Costa (www.gilcosta.com)

A large part of our genome is made up of potentially mobile pieces called transposons, also known as ‘jumping genes’ for their ability to change their position. While humans largely share the same genes in our DNA, the combination of transposons are unique for each person. Recent evidence uncovered in 2020 by Dr Christoph Treiber and Professor Scott Waddell in the Centre for Neural Circuits and Behaviour (CNCB) suggests that transposons are particularly active in the brain. This has given rise to a new hypothesis that transposons might change brain functions and contribute to the diversity of behaviours across individuals within a population.

Dr Christoph Treiber of the Waddell group has now been awarded a European Research Council (ERC) Starting Grant to begin an independent line of research to interrogate this hypothesis over the next five years. The award of more than £1.25 million will “help us understand whether our unique transposon fingerprint contributes to who we are. Transposons could be a key component of our personality.” (Dr Christoph Treiber).

With this new award, Dr Treiber will combine two novel and ground-breaking techniques to test the hypothesis in the fruit fly brain, a well-established model for studying how genes alter behaviours. The first, single-cell transcriptomics, has been pioneered by Dr Treiber and Dr Vincent Croset in the Waddell Group at the CNCB. The second, PacBio® single-molecule real-time (SMRT) sequencing generates full length cDNA sequences from cells and tissues.

Read the full story on the DPAG website. 

Similar stories

New research reveals relationship between particular brain circuits and different aspects of mental wellbeing

Researchers at the University of Oxford have uncovered previously unknown details about how changes in the brain contribute to changes in wellbeing.

Night-time blood pressure assessment is found to be important in diagnosing hypertension

Around 15% of people aged 40-75 may have a form of undiagnosed high blood pressure (hypertension) that occurs only at night-time. Because they do not know about this, and therefore are not being treated for it, they are at a higher risk of cardiovascular disease such as stroke, heart failure, and even death, suggests new research from the University of Oxford published in the British Journal of General Practice.

Major new NIHR Global Health Research Unit to focus on data science and genomic surveillance of antimicrobial resistance

The Centre for Genomic Pathogen Surveillance, part of the Big Data Institute at the University of Oxford, has been awarded funding worth £7m for their work as an NIHR Global Health Research Unit (GHRU) for the next five years. The Centre’s research and capacity building work focuses on delivering genomics and enabling data for the surveillance of antimicrobial resistance (AMR).

How artificial intelligence is shaping medical imaging

Dr Qiang Zhang of the Radcliffe Department of Medicine explains how artificial intelligence is being used to help researchers and physicians interpret medical imaging.

Researchers describe how cancer cells can defend themselves from the consequences of certain genetic defects

Researchers in Department of Physiology, Anatomy and Genetics have identified a rescue mechanism that allows cancers to overcome the consequences of inactivating mutations in critically important genes.